Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO‐incompatible liver transplant
- 16 May 2023
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 38 (5) , 548-554
Abstract
Introduction: Liver transplant is a life‐saving treatment, but due to the limited availability of suitable liver donors, ABO‐incompatible liver transplants (ABOi‐LT) are conducted to increase the availability of liver donors. Perioperative desensitization for ABOi‐LT is an established strategy to circumvent the risk of graft rejection. A single prolonged session can be performed to achieve the desired titers to avoid using multiple immunoadsorption (IA) columns or off‐label reuse of single‐use columns. This study retrospectively assessed the effectiveness of a single prolonged plasmapheresis session using IA as a desensitization strategy in live donor liver transplant (LDLT).Materials and methods: This retrospective observational study conducted at a center for liver diseases in North India on six ABOi‐LDLT patients who underwent single prolonged IA sessions in the perioperative period from January 2018 to June 2021.Results: Median baseline titer in patients was 320 (64, 1024). The median plasma volume adsorbed was 7.5 volumes (4, 8) per procedure, with a mean procedure time of 600 min (310‐753). The reduction in titer ranged from 4 log to 7 log reduction per procedure. Two patients developed transient hypotension during the procedure, which was managed successfully. The median duration of pre‐transplant hospital stay was 1.5 days (1, 3).Conclusion: Desensitization therapy helps overcome the ABO barrier and decreases the waiting period before a transplant when ABO identical donors are unavailable. A single prolonged IA session reduces the cost of additional IA columns and hospital stay, thus making it a cost‐effective approach to desensitization.Keywords
This publication has 16 references indexed in Scilit:
- Efficacy of single, extended and goal directed immunoadsorption in ABO incompatible living related donor liver transplantationTransfusion and Apheresis Science, 2016
- Current techniques for AB0-incompatible living donor liver transplantationWorld Journal of Transplantation, 2016
- ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive ManagementAmerican Journal of Transplantation, 2015
- ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With RituximabAmerican Journal of Transplantation, 2015
- The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is EfficientTransplantation, 2015
- Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT)Transplantation Research, 2014
- ABO-incompatible living donor liver transplantation without graft local infusion and splenectomyHPB, 2014
- Human Blood Groups2013
- Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center ExperienceJournal of Transplantation, 2009
- Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantationTransplantation, 2004